Skip to main content

COVID-19: Key Developments for FDA-Regulated Consumer Product Companies

April 1, 2020
Coronavirus: Multipractice Webinar

To help our clients navigate the coronavirus (COVID-19) crisis, Arnold & Porter has established a Coronavirus Task Force covering a wide range of issues and challenges. Subscribe to our "Coronavirus (COVID-19)" mailing list to receive our latest client Advisories and register for upcoming webinars.

How can manufacturers and retailers of FDA-regulated consumer products address operational, regulatory, employee and charitable-marketing issues in the face of COVID-19? What should companies know? In this webinar, we discuss key developments related to essential businesses, FDA priorities and developments, tips on engaging with employees while mitigating legal risk, and considerations related to charitable giving.

Meet the Speakers

Raqiyyah Pippins
Arnold & Porter
Joshua F. Alloy
Arnold & Porter
Bridget M. Weiss
Arnold & Porter